Eyevensys SA
Plasmid-based protein therapy for eye diseases
This article was originally published in Start Up
Executive Summary
French start-up Eyevensys SA believes it can improve upon current treatments for AMD, in both ease of administration and frequency of treatment, with a disposable device that injects plasmid-based protein therapies into the ciliary muscle.